000			01470 a2200385 4500
005			20250514180823.0
264		0	_c20040720
008			200407s 0 0 eng d
022			_a1055-0496
024	7		_a10.1111/j.1521-0391.2003.tb00496.x _2doi
040			_aNLM _beng _cNLM
100	1		_aAnton, Raymond F
245	0	0	_aCurrent pharmacotherapies of alcoholism: a U.S. perspective. _h[electronic resource]
260			_bThe American journal on addictions _c2003
300			_as53-s68 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAcamprosate
650	0	4	_aAlcohol Deterrents _xtherapeutic use
650	0	4	_aAlcoholism _xdrug therapy
650	0	4	_aAnticonvulsants _xtherapeutic use
650	0	4	_aClinical Trials as Topic
650	0	4	_aDrug Therapy, Combination
650	0	4	_aHumans
650	0	4	_aNaltrexone _xtherapeutic use
650	0	4	_aNarcotic Antagonists _xtherapeutic use
650	0	4	_aReceptors, Glutamate _xdrug effects
650	0	4	_aSerotonin Antagonists _xtherapeutic use
650	0	4	_aSerotonin Receptor Agonists _xtherapeutic use
650	0	4	_aSelective Serotonin Reuptake Inhibitors _xtherapeutic use
650	0	4	_aTaurine _xanalogs & derivatives
650	0	4	_aUnited States
700	1		_aSwift, Robert M
773	0		_tThe American journal on addictions _gvol. 12 _gno. s1 _gp. s53-s68
856	4	0	_uhttps://doi.org/10.1111/j.1521-0391.2003.tb00496.x _zAvailable from publisher's website
999			_c14694769 _d14694769